Given that sarcopenic obesity represents a distinct clinical phenotype characterized by the coexistence of excess fat and reduced muscle mass and function, it is crucial to assess how irisin and adiponectin are associated with obesity, sarcopenia and sarcopenic obesity simultaneously. Here, ADIPOQ is linked to obesity disorder.